Petrochemical giant highlights dangers of antibiotic resistance
A new institute for antimicrobial research will open at the University of Oxford, UK, following a major donation by one of the world’s largest chemical companies. Researchers at the facility will aim to develop new drugs to tackle antimicrobial resistance (AMR), which is linked to 1.5 million deaths each year.